Market Wrap: Citi Trounces Q2 Expectations; Merger Monday; Drug Stocks Active on Results - InvestingChannel

Market Wrap: Citi Trounces Q2 Expectations; Merger Monday; Drug Stocks Active on Results

Market wrap for July 14th

End of the Day: S&P 500 up 9.5 to 1,977.10; Dow Jones up 111.6 to 17,055.42; Nasdaq up 24.9 to 4,440.42

* Mylan Inc. (Nasdaq: MYL) announced that it has entered into a definitive agreement with Abbott (NYSE: ABT) whereby Mylan will acquire Abbott’s non-U.S. developed markets specialty and branded generics business (“the Assets”) in an all-stock transaction. Upon closing, Abbott will receive 105 million shares of the combined company worth approximately $5.3 billion based on Mylan’s closing price of $50.20 on Friday, July 11, 2014.

* Citigroup, Inc. (NYSE: C)